Concord Biotech Limited (BOM:543960)

Concord Biotech Statistics

Total Valuation

Concord Biotech has a market cap or net worth of INR 173.97 billion. The enterprise value is 171.16 billion.

Market Cap	173.97B
Enterprise Value	171.16B

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	24.92M

Valuation Ratios

The trailing PE ratio is 53.32.

PE Ratio	53.32
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	10.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	52.46
EV / Sales	15.71
EV / EBITDA	37.50
EV / EBIT	42.41
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	n/a
Interest Coverage	452.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	17.06%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	7.91M
Profits Per Employee	2.37M
Employee Count	1,377
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.97% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.97%
50-Day Moving Average	1,858.09
200-Day Moving Average	1,877.86
Relative Strength Index (RSI)	44.52
Average Volume (20 Days)	5,194

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Concord Biotech had revenue of INR 10.89 billion and earned 3.26 billion in profits. Earnings per share was 31.19.

Revenue	10.89B
Gross Profit	8.05B
Operating Income	4.06B
Pretax Income	4.40B
Net Income	3.26B
EBITDA	4.57B
EBIT	4.06B
Earnings Per Share (EPS)	31.19

Balance Sheet

The company has 2.84 billion in cash and 34.24 million in debt, giving a net cash position of 2.80 billion.

Cash & Cash Equivalents	2.84B
Total Debt	34.24M
Net Cash	2.80B
Net Cash Per Share	n/a
Equity (Book Value)	15.90B
Book Value Per Share	151.99
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 73.90%, with operating and profit margins of 37.23% and 29.96%.

Gross Margin	73.90%
Operating Margin	37.23%
Pretax Margin	40.37%
Profit Margin	29.96%
EBITDA Margin	41.93%
EBIT Margin	37.23%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 8.75, which amounts to a dividend yield of 0.51%.

Dividend Per Share	8.75
Dividend Yield	0.51%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	0.49%
Earnings Yield	1.88%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a